Arbutus Biopharma Corporation

ABUS · NASDAQ
Analyze with AI
$4.58−$0.065 (−1.4%)
At close:Dec 18, 2025, 5:09 PM UTC
$4.58+$0.00 (+0%)
After hours:Dec 18, 2025, 5:09 PM UTC
P/E TTM-20.75
P/B TTM11.34
P/S TTM60.2
Dividend Yield0%
EPS-$0.23
Beta0.656
Valuation
PEG Ratio-0.97
FCF Yield-5.16%
EV / EBITDA-20.22
More On Valuation »
Quality
ROIC-59.47%
Gross Margin32.69%
Cash Conv. Ratio1.07
More On Quality »
Growth
Revenue 3Y CAGR-45.92%
FCF Growth25.20%
More On Growth »
Safety
Net Debt / EBITDA0.51
Interest Coverage-878.37
More On Safety »
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle22.62
More On Efficiency »

Arbutus Biopharma Corporation (ABUS) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Arbutus Biopharma Corporation (ABUS) stock price today?

As of Dec 18, 2025, 5:09 PM UTC, Arbutus Biopharma Corporation (ABUS) stock is trading at $4.58. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date ABUS stock quotes for informed trading decisions.

What is Arbutus Biopharma Corporation's market capitalization?

Arbutus Biopharma Corporation (ABUS) has a market capitalization of approximately $879.2M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Arbutus Biopharma Corporation's size relative to other companies in the USD market. The market cap figure updates automatically as the ABUS stock price changes.

What is the 52-week range for Arbutus Biopharma Corporation stock?

Arbutus Biopharma Corporation (ABUS) stock has traded in a 52-week range of $2.71 — $5.10. The 52-week range shows the highest and lowest prices at which ABUS traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Arbutus Biopharma Corporation stock price to this range provides context for recent price action.

How much trading volume does Arbutus Biopharma Corporation stock have?

Arbutus Biopharma Corporation (ABUS) stock recently traded approximately 179K shares. Trading volume indicates market liquidity and investor interest in ABUS. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Arbutus Biopharma Corporation stock.

Does Arbutus Biopharma Corporation pay dividends to shareholders?

Yes, Arbutus Biopharma Corporation (ABUS) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Arbutus Biopharma Corporation stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Arbutus Biopharma Corporation's intraday price range?

Today, Arbutus Biopharma Corporation (ABUS) stock has traded in a range of $4.53 — $4.69. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring ABUS's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Arbutus Biopharma Corporation stock data?

AlphaPilot sources real-time ABUS stock quotes, fundamental financial data, and historical price charts for Arbutus Biopharma Corporation from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Arbutus Biopharma Corporation stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of ABUS stock performance.